At-a-Glance
Today’s Top Highlights
The main talking points over the last few months and even the entire year has been the rise in the precious metals and equity indices, and the last few weeks has been even more intense for markets like Gold, Silver, and Platinum. While that has dominated the news cycle, Crude Oil has been slowly grinding higher since the start of the year after bottoming out in late December of 2025. Crude prices opened on January 2nd near $57/barrell and after rising again today by over 3% the market closed near $65.50, which is close to a $10 move over the course of the New Year. The market has now risen out above its 50-day moving average and the 200-day moving average, which it has not done with much conviction since June of 2025.
Outside of the Crude market, the precious metals did see strong volatility today with Gold, Silver and Copper extending to new all time highs again today, marking the 8th straight of a record high price for Gold. In terms of data, Apple earnings were released after the close and saw a strong beat on EPS and Revenue, and traders also saw Initial Jobless Claims come in higher than expected, and the equity markets finished the day lower. Tomorrow, Chicago PMI and PPI will be released and traders will be eying the equity and precious metals markets as they are trading near record highs to wrap up the week.
Explore Additional Market Commentary
Traders Resources
The information in the market commentaries have been obtained from sources believed to be reliable, but we do not guarantee its accuracy and expressly disclaim all liability. Neither the information nor any opinions expressed therein constitutes a solicitation of the purchase or sale of any futures or options contracts. The information on this site compiled by CME Group is for general purposes only. All information and data herein is provided as-is. Additionally, all examples on this site are hypothetical situations, used for explanation purposes only, and should not be considered investment advice or the results of actual market experience. CME Group assumes no responsibility for any errors or omissions. CME Group, its affiliates and any third party information and content providers expressly disclaim all liability with respect to the information and data contained herein including without limitation, any liability with respect to the accuracy or completeness of any data. You use the data herein solely at your own risk. All data and information provided herein is not intended for trading purposes or for trading advice. All matters pertaining to rules and specifications herein are made subject to and superseded by official CME, CBOT, NYMEX and COMEX rules. Current rules should be consulted in all cases concerning contract specifications.
Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Due to the leveraged nature of futures trading and swaps trading, it is possible to lose more than the amount deposited in a position. Therefore, traders should not deposit more funds than they can afford to lose without negatively affecting their lifestyles. A trader cannot expect to profit on each trade, and should only devote a small amount of their available funds to each trade. All references to options refer to options on futures.
Past performance is not necessarily indicative of future performance.
CME Group, the Globe Logo, Chicago Mercantile Exchange, Globex and CME are trademarks of Chicago Mercantile Exchange Inc. CBOT is the trademark of the Board of Trade of the City of Chicago, Inc. NYMEX is the trademark of the New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. All other marks are the property of their respective owners. Each of Chicago Mercantile Exchange Inc. (ARBN 103 432 391), The Board of Trade of the City of Chicago Inc (ARBN 110 594 459), the New York Mercantile Exchange Inc (ARBN 113 929 436) and Commodity Exchange, Inc. (ARBN 622 016 193) is a registered foreign company in Australia and holds an Australian market licence.
This site does not constitute a prospectus, product disclosure statement or legal advice, nor is it a recommendation to buy, sell or retain any specific investment or to utilise or refrain from utilising any particular service. Readers should consult their legal advisors for legal advice in connection with the matters covered on this site.
